Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CASR | P41180 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | KRAS | P01116 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9088241 | 1.00 | MEN1 (0.50) | MEN1KMT2AALOX12CASRPKM | |
| SCHEMBL7206660 | 0.81 | CASR (0.54) | KMT2ACASRALDH1A1KDM4E | |
| SCHEMBL9089450 | 0.81 | CASR (0.54) | KMT2ACASRALDH1A1KDM4E | |
| SCHEMBL9088417 | 0.80 | LMNA (0.58) | MEN1KMT2AALOX12CASRPKM | |
| SCHEMBL7183804 | 0.80 | LMNA (0.58) | MEN1KMT2AALOX12CASRPKM | |
| SCHEMBL9087458 | 0.80 | LMNA (0.58) | MEN1KMT2AALOX12CASRPKM | |
| SCHEMBL15131268 | 0.80 | MEN1 (0.49) | MEN1KMT2ACASRHTTEGFR | |
| SCHEMBL15131121 | 0.78 | CASR (0.54) | MEN1KMT2ACASRHTTKRAS | |
| SCHEMBL7179578 | 0.76 | GAA (0.49) | MEN1KMT2AALOX12CASRPKM | |
| SCHEMBL3734404 | 0.76 | CASR (0.54) | KMT2ACASRALDH1A1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5510519-A | OPTICAL RESOLUTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-04-23 | — | — | US | claimed |
| EP-0508307-B1 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL CO (JP) | 1995-11-29 | — | — | EP | claimed |
| US-5298660-A | Compound containing an assymetrical carbon atom | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0508307-A2 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-10-14 | — | — | EP | claimed |
| EP-0933349-B1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL CO (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-09-05 | — | — | US | disclosed |
| EP-1236708-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-04 | — | — | EP | disclosed |
| US-6268525-B1 | REACTING CHRYSANTHEMIC ACID HAVING TRANS ISOMER WITH OPTICALLY ACTIVE AMINE TO OPTICALLY RESOLVE CHRYSANTHEMIC ACID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-31 | — | — | US | disclosed |
| EP-0933349-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-08-04 | — | — | EP | disclosed |
| US-5510519-A | OPTICAL RESOLUTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0508307-B1 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL CO (JP) | 1995-11-29 | — | — | EP | disclosed |
| US-5298660-A | Compound containing an assymetrical carbon atom | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-03-29 | — | — | US | disclosed |
| EP-0508307-A2 | Optically active secondary amine compound; process for producing optically active secondary amine compound and process for producing optically active carboxylic acid by using said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | ENO1, CYP8B1, CRYAA | MEN1 1048/4885KMT2A 4324/4885ALOX12 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.